What is the significance of the 10-day moving average indicator for CNCR?

The 10-day moving average for CNCR crossed bullishly above the 50-day moving average on July 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

CNCR

AS OF

May 27 closing price

Price

$9.02

Change

+$0.14 (+1.58%)

Net Assets

6.95M

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

+Compare

CNCR

ETF ticker:

AS OF

May 27 closing price

Price

$9.02

Change

+$0.14 (+1.58%)

Net Assets

6.95M

CNCR stock forecast, quote, news & analysis

Q: How does the Aroon Indicator reflect on CNCR's trend?

The Aroon Indicator entered an Uptrend today. In 136 of 172 cases where CNCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Get AI intraday signals

CNCR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CNCR
(Try 14 days for Free)

A.I.Advisor

published price charts

View AI-Driven Trading

Interact to see
Advertisement

A.I.Advisor

a Summary for CNCR with price predictions

Jul 22, 2025

CNCR in upward trend: 10-day moving average moved above 50-day moving average on July 16, 2025

The 10-day moving average for CNCR crossed bullishly above the 50-day moving average on July 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

CNCR moved above its 50-day moving average on July 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 172 cases where CNCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

A.I.Advisor

published Highlights

Notable companies

The most notable companies in this group are Merck & Co (NYSE:MRK), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN), Exelixis (NASDAQ:EXEL).

Market Cap

The average market capitalization across the Range Cancer Therapeutics ETF ETF is 8.85B. The market cap for tickers in the group ranges from 7.17M to 331.75B. MRK holds the highest valuation in this group at 331.75B. The lowest valued company is APLM at 7.17M.

High and low price notable news

The average weekly price growth across all stocks in the Range Cancer Therapeutics ETF ETF was 0%. For the same ETF, the average monthly price growth was 0%, and the average quarterly price growth was -28%. IOVA experienced the highest price growth at 61%, while REPL experienced the biggest fall at -77%.

Volume

The average weekly volume growth across all stocks in the Range Cancer Therapeutics ETF ETF was 53%. For the same stocks of the ETF, the average monthly volume growth was 18% and the average quarterly volume growth was 112%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51

P/E Growth Rating: 79

Price Growth Rating: 55

SMR Rating: 90

Profit Risk Rating: 95

Seasonality Score: -10 (-100 ... +100)

View a ticker or compare two or three

Compare

CNCR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CNCR
(Try 14 days for Free)

Interact to see
Advertisement

A.I. Advisor

published General Information

General Information

Category Unknown

Profile

Fundamentals

Details